NCT06439823 Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function
| NCT ID | NCT06439823 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Laurent Servais |
| Condition | Neuromuscular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-08-24 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-08-24 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of the study is to validate the algorithms developed to analyze the signals from the various sensors contained in the magneto-inertial control units and reconstruct upper and lower limb movements under different normal and pathological conditions.
Eligibility Criteria
Inclusion Criteria: * Subjects over 2 years old * Male or female * Control subjects with no pathologies that have an impact on ambulation or motor function. * Signed informed consent and, in the case of minors, informed consent signed by the person with parental authority/guardian Exclusion Criteria: * Any other previous or present pathology having an impact on current motor or balance function * Recent surgery or trauma to upper or lower limbs, or major surgery or trauma within 6 months of inclusion. * For control subjects, athlete of at least national level. * Pregnant or breast-feeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06439823 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, studying Neuromuscular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06439823 currently recruiting?
Yes, NCT06439823 is actively recruiting participants. Contact the research team at laurie.medard@citadelle.be for enrollment information.
Where is the NCT06439823 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT06439823 clinical trial?
NCT06439823 is sponsored by Laurent Servais. The trial plans to enroll 200 participants.